ClearSky Medical Diagnostics
  • About Us
  • Products
    • LID-Monitor
    • PD-Monitor
    • CF-Monitor
    • ND-Monitor
  • Clinical Studies
  • News
  • Services
  • Pharma Trials
  • Contact
  • English
    • 简体中文
Select Page
Partners Wanted to Accelerate Development of Mild Cognitive Impairment Diagnostic Device

Partners Wanted to Accelerate Development of Mild Cognitive Impairment Diagnostic Device

by clearskymd | Mar 24, 2022 | Company News

ClearSky Medical Diagnostics has developed an intelligent medical device that can objectively diagnose mild cognitive impairment (MCI), a condition often suggested as an early stage of dementia. It is estimated that between five and 20 per cent of people aged over 65...
ClearSky’s AI technology supports the novel research of children’s brain health

ClearSky’s AI technology supports the novel research of children’s brain health

by clearskymd | Jan 11, 2022 | Company News

ClearSky Medical Diagnostics is supporting a new initiative to better understand the development of children’s brains during their early stages of life. The Wellcome Leap Program’s The First 1000 Days – Promoting Healthy Brain Networks project focuses on the...
Clearsky Secures Licensing Deal for Commercialisation of PD-Monitor in China

Clearsky Secures Licensing Deal for Commercialisation of PD-Monitor in China

by clearskymd | Dec 8, 2021 | Company News

ClearSky Medical Diagnostics and Shanghai Accurature Diagnostics Co Ltd have entered into a strategic cooperation agreement related to PD-Monitor. PD-Monitor is a medical device using ClearSky’s proprietary AI technology to assist the diagnosis and measurements of...
ClearSky features at UK–China university consortium

ClearSky features at UK–China university consortium

by clearskymd | Dec 14, 2020 | Company News

Professor Stephen Smith highlighted the work of ClearSky Medical Diagnostics in diagnosing and monitoring Parkinson’s at a UK–China university consortium in November. The UK-Jiangsu World-Class University Consortium is a group of more than 30 leading...
Parkinson’s and statins: PD-Monitor in clinical study

Parkinson’s and statins: PD-Monitor in clinical study

by clearskymd | Nov 16, 2020 | Company News

ClearSky’s PD-Monitor has been used in a major UK study to investigate whether statins are effective in slowing the progress of Parkinson’s. Statins, such as Simvastatin, are a group of medicines that are currently prescribed to lower cholesterol in the blood....
Global recognition for ClearSky Medical Diagnostics

Global recognition for ClearSky Medical Diagnostics

by clearskymd | Sep 24, 2020 | Company News

ClearSky Medical Diagnostics is recognised as an ‘up and coming’ company tackling neurodegenerative disease through technology. Data science company StartUs Insights, which identifies startups, disruptive technologies and new business models early-on, selected...
« Older Entries
Next Entries »

Search

Recent Posts

  • Webinar Puts on Spotlight on Personalised Digital Health
  • ClearSky MD is a UK Life Sciences Innovator 2023
  • ClearSky presents at MEDICA 2022 in Germany
  • ClearSky heads to 2022 MDS International Congress in Madrid
  • SCOR Innovation Podcast: Interview with Professor Smith

Recent Comments

    Archives

    • November 2023
    • February 2023
    • December 2022
    • September 2022
    • June 2022
    • April 2022
    • March 2022
    • January 2022
    • December 2021
    • December 2020
    • November 2020
    • September 2020
    • July 2020
    • February 2020
    • October 2019
    • July 2019
    • June 2019
    • May 2019
    • April 2019
    • January 2019
    • December 2018
    • September 2018
    • July 2018
    • June 2018
    • May 2018
    • April 2018
    • March 2018
    • February 2018
    • October 2017
    • September 2017
    • August 2017
    • July 2017
    • May 2017

    Categories

    • Blog
    • Company News
    • Parkinson's
    • Facebook
    • X
    © ClearSky Medical Diagnostics 2022 // Privacy Policy // Cookie Policy